Replies to post #122148 on Biotech Values

[mcbio]

I’m not ready to go that far, but it does look more and more like the SoC for most patients in a few years is not going to be a PI + ifn + ribavirin.

I definitely agree with that. I will take your response as being on the fence with perhaps a slight lean to the pro-ACHN side. ; )